Industry Projects | Projects by Region | Projects by Category | Archived Projects | Project Gallery
 

AM103



AM103 is a novel inhibitor of 5-lipoxygenase activating protein (FLAP) under development as a potential treatment for asthma.


Back to Project Details



Related Projects

Fablyn (Lasofoxifene) - Investigational SERM
The product of a joint development programme between Pfizer and...

Capravirine - Anti-Retroviral Drug
Developed by Pfizer Global Research and Development, capravirine is...

Avastin (bevacizumab) - Angiogenesis
The product of a joint development programme between Genentech and...

Xolair - Biological Therapy
The product of a joint development programme between Tanox, Genentech...

Tarceva - Small Molecule
Tarceva (erlotinib) is an oral anti-cancer drug developed by...

See all projects


Contact us
Advertise with us
Terms and conditions
Privacy
Links
Newsletter sign up
Online magazine sign up

drugdevelopment-technology.com is a product of Net Resources International. Copyright 2011 Net Resources International, a trading division of SPG Media Limited.